FOLH1 and neoplasm: As a result, the tumor dose at maximum injectable activity was 177Lu-EB-PSMA-617 (60.1 Gy), and 177Lu-PSMA-ALB-56 (96 Gy) was significantly lower than 177Lu-PSMA-671 (131 Gy).